Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...

A new type of bioengineered blood vessel showed strong results in treating severe vascular injuries, potentially offering vascular surgeons a better alternative to synthetic grafts when patients' ...

A new bioengineered neuronal circuit board "BioConNet" allows scientists to artificially engineer human brain-like wiring at scale and can be used to engineer any possible circuit. The fully ...